Study design
ARF
ARF, AIRWAY OBSTRUCTION
A randomized, controlled, monocentric open-label, parallel clinical study was
conducted in a 25-bed medical ICU unit in France. All consecutive patients
meeting the inclusion criteria were enrolled and randomized into a Control Group
(performing CCPT) or MI-E Group (CCPT associated with MI-E). Randomization was
centralized via secured electronic software (SAS v 9.3, SAS Institute Inc, Cary,
NC, USA) balanced in a 1:1 ratio using a size block of 6 or 8 randomly and was
performed one hour after extubation to guarantee that patients did not present
immediate ARF due to upper airway obstruction.The presented study was approved by the corresponding Institutional Review Board
(no 2011-A01459-32), which waived the need for informed consent.